Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Relative Risk
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Standards of Care II
Healthcare Associated Infections II: Preventive Measures
Acute Coronary Syndrome V: Nursing Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 25, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Didem Egemen1, Li C Cheung1, Xiaojian Chen1
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
New guidelines for cervical cancer screening abnormalities offer 6 clinical actions based on risk of high-grade abnormalities. This study details the risk estimates supporting these evidence-based recommendations for human papillomavirus (HPV) and cytology testing.
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: